3 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Terminated 3 |
Follow Urticaria: new trials by email Literature Review of Urticaria trials Research Report on Urticaria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| C1-inhibitor in Allergic ASThma Patients C1-inhibitor, Saline, Antibiotics - Asthma | Phase 4 | Terminated | T. van der Poll | 37 | 2016-11-16 | 2020-06-24 |
| Effect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated Angioedema icatibant, Placebo - ACE Inhibitor-associated Angioedema | Phase 4 | Terminated | Vanderbilt University Medical Center | 33 | 2011-08-01 | 2017-02-17 |
| A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736) Desloratadine, Cetirizine, placebo - Urticaria | Phase 4 | Terminated | Organon and Co | 149 | 2004-03-01 | 2024-08-15 |
Angioedema (1) · Angioedemas, Hereditary (1) · Asthma (1)
Hypersensitivity (3) · Hypersensitivity, Immediate (3) · Immune System Diseases (3) · Skin Diseases (3) · Skin Diseases, Vascular (3) · Skin and Connective Tissue Diseases (3) · Cardiovascular Diseases (2) · Vascular Diseases (2) · Angioedema (1) · Bronchial Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hereditary Complement Deficiency Diseases (1) · Immunologic Deficiency Syndromes (1)
Anti-Bacterial Agents (1) · Cetirizine (1) · Ciprofloxacin (1) · Complement C1 Inhibitor Protein (1) · Metronidazole (1) · SERPING1 protein, human (1) · Sodium Chloride (1) · Vancomycin (1) · desloratadine (1) · icatibant (1)
Organon and Co (1) · T. van der Poll (1) · Vanderbilt University Medical Center (1)
Netherlands (1) · United States (1)